This study is not recruiting (status: Active, not recruiting).
It is no longer listed as an open opportunity. The official record is linked below for reference. Find recruiting studies.
A Study Of Effect Of Secretin For In Injection (Chirostim) On Pancreatic Fluid Composition In Healthy Subjects
Mayo Clinic · with ChiRhoClin, Inc. · NCT07285863
Key facts
- Compensation
- Not listed in the record
- Who can join
- 18 Years to 80 Years · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Phase 4
- Target enrollment
- 24
- US sites recruiting
- 1
- Study start
- March 11, 2026
- Record last updated
- October 26, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The purpose of this study is to collect pancreas fluid from the duodenum using the endoscopic pancreas function collection method in healthy participants after pancreatic stimulation with human secretin.
Being studied: Secretin (human synthetic) - ChiRhoClin
Conditions: Exocrine Pancreatic Insufficiency; Chronic Pancreatitis
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Males or non-pregnant females
- Age 18-80.
- Participants must be in good health based on medical history (ASA Class 3 or below)
- Participants must be willing and able to provide informed consent
- Receiving an endoscopic ultrasound for a non-pancreatic indication
Exclusion Criteria
- History of any form of pancreatitis and/or other pancreatic diseases (e.g. pancreatic cysts, pancreatic masses).
- History of inflammatory bowel disease
- History of vagotomy.
- History of surgically altered upper gastrointestinal anatomy (e.g. gastric bypass, Billroth I/II)
- History of liver disease
- Pregnant women or nursing mothers
- Regular use of anticholinergics
- > 2 drinks of alcohol daily
- Smokers (cigarette)
Recruiting US locations
Mayo Clinic in Rochester
Rochester, MN 55905